Tushar Srivastava

5PUBLICATIONS
19CO-AUTHORS
Computational physiologyMedical molecular engineering of nucleic acids and proteinsWastewater treatment processesEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 12, 2026
Conceptualising Health Economic Models Using a Graph Retrieval-Augmented, Agentic AI Framework with Human-in-the-Loop Validation: Proof-of-Concept Study.

|Nov 02, 2024
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Sue Harnan, Ben Kearns, Alison Scope

|Jun 28, 2024
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Beth Woods, Laetitia Schmitt, Dina Jankovic

|May 19, 2021
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals.

Tushar Srivastava, Nicholas R Latimer, Paul Tappenden

|Nov 03, 2020
Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia.

Masnoon Saiyed, Joshua Byrnes, Tushar Srivastava

Pageof 1

Frequent Collaborators

2 joint publications

Jean Hamilton

2 joint publications

Claire Rothery

2 joint publications

Chu Chang Ku

2 joint publications

Laura Bojke